Back
LU7
Lithium Universe Limited
🇦🇺 ASX
⛏️ MINING
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
7
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Lithium Universe Ltd. engages in the business of design and development of its online media platform. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2011-10-19. The firm is dedicated to securing the future of green energy by addressing two strategic initiatives: the development of a green, battery-grade lithium carbonate refinery in Quebec, Canada, and pioneering the recycling of valuable metals, including silver, from discarded solar panels. The company has rights to patented PV solar panel recycling technology known as Microwave Joule Heating Technology. Its projects include Apollo Lithium Project, Adina South & Adina West Lithium Project, Margot Lake Lithium Project, Lefroy Lithium Project, Voyager Rare Earth Project. The Apollo Lithium Project is located in the same greenstone belt and only 29 kilometers south-east of the Corvette Lithium Project and covers over 240 square kilometers (km2). The Adina Projects are situated in proximity to the Adina discovery.
📈 Performance
Price History
-7.14%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.01
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in LU7
7
📊 Total Capital Earnings
$-843.02
🔃 Average investment frequency
16 weeks
💵 Average investment amount
$867
⏰ Last time a customer invested in LU7
19 days
LU7 investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
13%
50k - 100k
38%
Less than 50k
50%
👶 Age of investors
18 - 25
14%
26 - 34
35 - 90
86%
🙋 Legal gender of investors
Female
Male
100%
Pearlers who invest in LU7 also invest in...
IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
23.41%
📊 Share price
$67.97 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
DHHF is an all-in-one investment solution, constructed using a passive blend of cost-effective ETFs traded on the ASX and other global exchanges. The ETF has a 100% allocation to shares, and is invested in a blend of large, mid and small cap equities from Australia, global developed and emerging markets, offering investors exposure to an ‘all-cap, all-world’ share portfolio with the potential for high growth over the long term. The ETF provides exposure to approximately 8,000 equity securities listed on over 60 global exchanges, in one ASX trade.
🙌 Performance (5Yr p.a)
14.07%
📊 Share price
$40.10 AUD
📈 HIGH PRICE GROWTH
🌏 GLOBAL
Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the provision of business of researching and developing dermatology and antimicrobial products. The company is headquartered in Perth, Western Australia. The Company’s lead product is Sofdra (sofpironium) topical gel, 12.45%, a prescription anticholinergic medicine used on the skin (topical), to treat excessive underarm sweating (primary axillary hyperhidrosis) in adults and children nine years of age and older. Sofdra regulates sweating at the site of application, by binding to the primary sweat receptor and thereby blocking the sweat signal. Its product pipeline targets the various skin diseases, such as BTX 1503 for Acne, BTX 1702 for Rosacea, BTX 1204A for Atopic Dermatitis, and BTX 1801 for Hemodialysis Patients. Its BTX 1503 is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. BTX 1702 is used for the treatment of papulopustular rosacea. BTX 1801 is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus (MRSA).
🙌 Performance (5Yr p.a)
13.00%
📊 Share price
$0.17 AUD
📈 HIGH PRICE GROWTH
📦 LOGISTICS
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
🙌 Performance (5Yr p.a)
22.61%
📊 Share price
$55.78 AUD
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
Want more shares? Try these...
